Scientists have identified a new anti-ageing drug class that works by acting on a key gut bacteria process, an advance that may lead to ways to prolong lifespan in humans.
Researchers from Queen Mary University of London have demonstrated that the new drug prolongs lifespan in yeast by acting on a pathway, which is also active in humans.